YoVDO

The Era of ADCs in the Treatment of NSCLC

Offered By: HMP Education via YouTube

Tags

Oncology Courses Clinical Trials Courses Cancer Treatment Courses Precision Medicine Courses Drug Development Courses Biomarkers Courses Targeted Therapy Courses Immunotherapy Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the evolving landscape of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) treatment through this informative 33-minute video. Gain insights into the latest advancements, clinical applications, and potential benefits of ADCs in improving outcomes for NSCLC patients. Delve into the mechanisms of action, efficacy data, and safety profiles of emerging ADC therapies. Understand how these targeted treatments are reshaping the therapeutic approach to NSCLC and their implications for patient care. Healthcare professionals can earn Continuing Medical Education (CME) credits by completing the associated program.

Syllabus

The Era of ADCs in the Treatment of NSCLC


Taught by

HMP Education

Related Courses

Cancer in the 21st Century: The Genomic Revolution
University of Glasgow via FutureLearn Inside Cancer: How Genes Influence Cancer Development
University of Bath via FutureLearn Cancer Immunotherapy: a Step Change in Cancer Treatment
University of Birmingham via FutureLearn Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Discovering Science: Medicinal Chemistry
University of Leeds via FutureLearn